These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

714 related articles for article (PubMed ID: 28849345)

  • 1. Gut microbiota and chronic kidney disease: implications for novel mechanistic insights and therapeutic strategies.
    Pan W; Kang Y
    Int Urol Nephrol; 2018 Feb; 50(2):289-299. PubMed ID: 28849345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Renal Clinician's Guide to the Gut Microbiota.
    Snelson M; Biruete A; McFarlane C; Campbell K
    J Ren Nutr; 2020 Sep; 30(5):384-395. PubMed ID: 31928802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota and chronic kidney disease: evidences and mechanisms that mediate a new communication in the gastrointestinal-renal axis.
    Rukavina Mikusic NL; Kouyoumdzian NM; Choi MR
    Pflugers Arch; 2020 Mar; 472(3):303-320. PubMed ID: 32064574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the gastrointestinal tract and microbiota on uremic toxins and chronic kidney disease development.
    Briskey D; Tucker P; Johnson DW; Coombes JS
    Clin Exp Nephrol; 2017 Feb; 21(1):7-15. PubMed ID: 26965149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of altered intestinal microbiota in systemic inflammation and cardiovascular disease in chronic kidney disease.
    Mafra D; Lobo JC; Barros AF; Koppe L; Vaziri ND; Fouque D
    Future Microbiol; 2014; 9(3):399-410. PubMed ID: 24762311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathomechanism and treatment of gut microbiota dysbiosis in chronic kidney disease and interventional effects of Chinese herbal medicine].
    Han WB; Liu YL; Wan YG; Sun W; Tu Y; Yang JJ; Wu W; He WM; Yao J
    Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2425-2432. PubMed ID: 28840678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): A Randomized Trial.
    Rossi M; Johnson DW; Morrison M; Pascoe EM; Coombes JS; Forbes JM; Szeto CC; McWhinney BC; Ungerer JP; Campbell KL
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):223-31. PubMed ID: 26772193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary Components That May Influence the Disturbed Gut Microbiota in Chronic Kidney Disease.
    Mafra D; Borges N; Alvarenga L; Esgalhado M; Cardozo L; Lindholm B; Stenvinkel P
    Nutrients; 2019 Feb; 11(3):. PubMed ID: 30818761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Kidney-Gut Axis: Implications for Nutrition Care.
    Rossi M; Johnson DW; Campbell KL
    J Ren Nutr; 2015 Sep; 25(5):399-403. PubMed ID: 25812908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral iron supplementation: Potential implications for the gut microbiome and metabolome in patients with CKD.
    Kortman GAM; Reijnders D; Swinkels DW
    Hemodial Int; 2017 Jun; 21 Suppl 1():S28-S36. PubMed ID: 28328083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistant starch for modulation of gut microbiota: Promising adjuvant therapy for chronic kidney disease patients?
    Moraes C; Borges NA; Mafra D
    Eur J Nutr; 2016 Aug; 55(5):1813-21. PubMed ID: 26830416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does the Composition of Gut Microbiota Affect Chronic Kidney Disease? Molecular Mechanisms Contributed to Decreasing Glomerular Filtration Rate.
    Młynarska E; Budny E; Saar M; Wojtanowska E; Jankowska J; Marciszuk S; Mazur M; Rysz J; Franczyk B
    Int J Mol Sci; 2024 Sep; 25(19):. PubMed ID: 39408756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbiome modulation as a novel therapeutic approach in chronic kidney disease.
    Sumida K; Lau WL; Kovesdy CP; Kalantar-Zadeh K; Kalantar-Zadeh K
    Curr Opin Nephrol Hypertens; 2021 Jan; 30(1):75-84. PubMed ID: 33148949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Could physical exercise help modulate the gut microbiota in chronic kidney disease?
    Esgalhado M; Borges NA; Mafra D
    Future Microbiol; 2016 May; 11():699-707. PubMed ID: 27159232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiota metabolites: Pivotal players of cardiovascular damage in chronic kidney disease.
    Cosola C; Rocchetti MT; Cupisti A; Gesualdo L
    Pharmacol Res; 2018 Apr; 130():132-142. PubMed ID: 29518493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probiotics and chronic kidney disease.
    Koppe L; Mafra D; Fouque D
    Kidney Int; 2015 Nov; 88(5):958-66. PubMed ID: 26376131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of lactulose on renal function and gut microbiota in adenine-induced chronic kidney disease rats.
    Sueyoshi M; Fukunaga M; Mei M; Nakajima A; Tanaka G; Murase T; Narita Y; Hirata S; Kadowaki D
    Clin Exp Nephrol; 2019 Jul; 23(7):908-919. PubMed ID: 30895529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emodin via colonic irrigation modulates gut microbiota and reduces uremic toxins in rats with chronic kidney disease.
    Zeng YQ; Dai Z; Lu F; Lu Z; Liu X; Chen C; Qu P; Li D; Hua Z; Qu Y; Zou C
    Oncotarget; 2016 Apr; 7(14):17468-78. PubMed ID: 27003359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The gut-kidney-heart axis in chronic kidney disease.
    Sumida K; Kovesdy CP
    Physiol Int; 2019 Sep; 106(3):195-206. PubMed ID: 31560235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiota issue in CKD: how promising are gut-targeted approaches?
    Cosola C; Rocchetti MT; Sabatino A; Fiaccadori E; Di Iorio BR; Gesualdo L
    J Nephrol; 2019 Feb; 32(1):27-37. PubMed ID: 30069677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.